CD19 and neoplasm: Wang, Y et al. [109••] pre-treated CD19 CAR-T cells with low-dose DAC (10nM) and found that DAC had a demethylating effect on CAR-T cells, reduced CAR-T cell depletion, and enhanced CAR-T proliferation and anti-tumor function in vitro and in mouse models.